Information Provided By: 
Fly News Breaks for October 29, 2019
OFIX
Oct 29, 2019 | 07:04 EDT
Cantor Fitzgerald analyst Craig Bijou downgraded Orthofix Medical to Neutral from Overweight with a price target of $47, down from $71. The company reported a "disappointing" quarter and recent management vacancies create uncertainty for the near-term growth of the business, Bijou tells investors in a research note. Orthofix could build a strong spine team, but it may take some time to regain some of the momentum it had earlier in the year, contends the analyst.
News For OFIX From the Last 2 Days
There are no results for your query OFIX
